healthcare
Patients could keep 340B drugs at partner pharmacies
The rewrite gives clinics and hospitals room to keep their existing pharmacy networks. It also adds reporting, a Medicaid study and rules meant to prevent duplicate discounts.
For patients who depend on safety-net providers, the issue is whether discounted medicines still move through nearby partner pharmacies. Illinois would block interference with those 340B arrangements and spell out new reporting and compliance rules for providers.
- The bill is being rewritten into the Patient Access to Pharmacy Protection Act.
- It focuses on 340B, the federal discount program for certain safety-net providers.
- Illinois would back contract pharmacies, including some outside the state.
- Recorded votes show the bill cleared a floor vote.
- Illinois is rewriting this measure into the Patient Access to Pharmacy Protection Act, turning a bill once labeled for dental insurance into a fight over discounted prescription access
Illinois is rewriting this measure into the Patient Access to Pharmacy Protection Act, turning a bill once labeled for dental insurance into a fight over discounted prescription access. The practical question is whether safety-net providers can keep using contract pharmacies to receive and dispense 340B drugs for the people they serve.
340B is the federal drug-discount program used by certain hospitals and clinics to stretch limited pharmacy budgets. For patients, that kind of arrangement can determine how far a clinic’s medication supply goes and whether a provider can keep prescriptions moving without cutting back elsewhere.
The partner pharmacy model
The rewritten text defines a 340B contract pharmacy as a pharmacy under contract with a 340B covered entity to dispense 340B drugs on the entity’s behalf. That reach matters because the definition includes some pharmacies outside Illinois, not just drugstores inside the state.
A 340B covered entity, in the bill’s wording, is an Illinois entity that qualifies under the federal Public Health Service Act’s 340B program. The amendment also says the federal statute is silent on how 340B-acquired drugs are distributed to covered entities and their pharmacy partners.
Why the state says it should act
The findings say Illinois has a compelling interest in preserving and improving access to health care services and that regulating the acquisition and delivery of drugs to pharmacies and providers falls within the state’s traditional authority. It frames access to these medications as a matter of health, safety and welfare.
That is the heart of the bill’s case: if contract-pharmacy arrangements narrow, patients served by 340B providers could feel the squeeze when they try to get the medicines those clinics are supposed to make easier to reach. Recorded votes show the bill cleared a floor vote.